Unraveling genetic predisposition and oxidative stress in vitiligo development and the role of artificial intelligence (AI) in diagnosis and management
Open Access
- 1 January 2025
- journal article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 44 (4) , 713-723
Abstract
Vitiligo is an autoimmune disorder with a complex genetic and epigenetic aetiology, characterised by progressive skin depigmentation. Recent advancements in artificial intelligence (AI) have greatly impacted the understanding, diagnosis, and treatment of vitiligo. The genetic basis of vitiligo is linked to multiple single nucleotide polymorphisms (SNPs) in genes associated with immune function, apoptosis, and melanogenesis, necessitating the integration of AI for more efficient diagnostic tools and personalised therapies. Genome-wide association studies (GWAS) have identified approximately 50 vitiligo-susceptibility genes, including PTPN1, PTPN22, NLRP1, FASLG, and TYR. These genes influence the immune response and melanocyte function, with the transcription factor Nuclear Factor kappa B (NF-kB), playing a central role in inflammatory responses and redox signaling induced by oxidative stress, in conjunction with antioxidant enzymes such as GPx, GST, SOD, and CAT. AI technologies offer a promising avenue for diagnosing vitiligo by combining genetic, clinical, and imaging data, allowing for more accurate classification and personalised treatment strategies. By analysing vast datasets, AI algorithms can identify patterns within complex genetic markers and clinical features, facilitating earlier and more precise detection of vitiligo. Furthermore, AI-driven approaches can optimise therapeutic monitoring, enabling real-time treatment efficacy and disease progression assessment. Integrating AI in vitiligo genetic diagnostics can revolutionise the monitoring of the disorder, improving patient outcomes through personalised, data-driven interventions.Keywords
This publication has 57 references indexed in Scilit:
- Estimating the burden of vitiligo: a systematic review and modelling studyThe Lancet Public Health, 2024
- Evaluation of Facial Vitiligo Severity with a Mixed Clinical and Artificial Intelligence ApproachJournal of Investigative Dermatology, 2023
- Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligoArchives of Biochemistry and Biophysics, 2020
- Family Clustering of Autoimmune Vitiligo Results Principally from Polygenic Inheritance of Common Risk AllelesThe American Journal of Human Genetics, 2019
- Genetics of VitiligoDermatologic Clinics, 2017
- Vitiligo as a systemic diseaseClinics in Dermatology, 2014
- Association of glutathione S-transferase M1/T1 polymorphisms with susceptibility to vitiligoGene, 2014
- Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligoFree Radical Biology and Medicine, 2013
- Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humansPeptides, 2005
- Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their FamiliesPigment Cell Research, 2003